Moreover, a direct relationship between EZH2 and TIMP2/3-tissue inhibitors of metalloproteinase-results in enhanced proteolytic activity of MMP-9 in prostate cancer cells [81]. The gene discussed is EZH2; the disease is prostate carcinoma.